Showing results (3791-3800 of 6,740) with videos related to
Sort By:
Pageof 674
Oncotargets and Therapy|June 1, 2013
Profile of erlotinib and its potential in the treatment of advanced ovarian carcinomaHal W HirteOncotargets and Therapy|June 1, 2013
Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinomaJie Luo, Ming Chen, Hengliu Huang, et al.Oncotargets and Therapy|May 14, 2013
Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumorsBénédicte L'heureux-Lebeau, Issam SalibaOncotargets and Therapy|April 10, 2013
Surgery in asymptomatic patients with colorectal cancer and unresectable liver metastases: the authors' experienceCarlo Boselli, Claudio Renzi, Alessandro Gemini, et al.Oncotargets and Therapy|April 27, 2013
Bevacizumab in high-grade gliomas: a review of its uses, toxicity assessment, and future treatment challengesGazanfar Rahmathulla, Elizabeth J Hovey, Neda Hashemi-Sadraei, et al.Oncotargets and Therapy|June 8, 2013
The different radiosensitivity when combining erlotinib with radiation at different administration schedules might be related to activity variations in c-MET-PI3K-AKT signal transductionHong-Qing Zhuang, Qi-Fu Bo, Zhi-Yong Yuan, et al.Oncotargets and Therapy|August 1, 2013
Gamma secretase inhibitors of Notch signalingRoma Olsauskas-Kuprys, Andrei Zlobin, Clodia OsipoOncotargets and Therapy|July 23, 2013
Circulating nucleic acids in plasma and serum (CNAPS): applications in oncologyJosé A González-Masiá, Damián García-Olmo, Dolores C García-OlmoOncotargets and Therapy|July 23, 2013
A miR-SNP of the XPO5 gene is associated with advanced non-small-cell lung cancerCuimin Ding, Cuiqiao Li, Hongjing Wang, et al.Oncotargets and Therapy|June 19, 2013
Current management options for recurrent adrenocortical carcinomaAnthony R Glover, Julian C Y Ip, Jing Ting Zhao, et al.Pageof 674